Alzheimer Disease [electronic resource] : Neuropsychology and Pharmacology | Emilien, Gérard, Durlach, Cécile, Minaker, Kenneth Lloyd, Winblad, Bengt, Gauthier, Serge, Maloteaux, Jean-Marie
![Alzheimer Disease [electronic resource] : Neuropsy](https://archive.org/services/img/springer_10.1007-978-3-0348-7842-5)
Share on TelegramAlzheimer Disease [electronic resource] : Neuropsychology and Pharmacology
User Rating: Be the first one!
Author: Emilien, Gérard, Durlach, Cécile, Minaker, Kenneth Lloyd, Winblad, Bengt, Gauthier, Serge, Maloteaux, Jean-Marie
Added by: sketch
Added Date: 2015-12-29
Publication Date: 2004
Language: eng
Subjects: Alzheimer's disease, Alzheimer's disease, Alzheimer's disease, Alzheimer's disease
Publishers: Basel : Birkhäuser Basel : Imprint : Birkhäuser
Collections: folkscanomy miscellaneous, folkscanomy, additional collections
ISBN Number: 9783034878425, 3034878427, 9783034895910, 3034895917
Pages Count: 600
PPI Count: 600
PDF Count: 1
Total Size: 558.31 MB
PDF Size: 31.19 MB
Extensions: djvu, epub, gif, pdf, gz, zip, torrent, log, mrc
Downloads: 1.69K
Views: 51.69
Total Files: 19
Media Type: texts
Description
Alzheimer Disease: Neuropsychology and Pharmacology
Author: Dr. Gérard Emilien, Dr. Cécile Durlach, Dr. Kenneth Lloyd Minaker, Professor Bengt Winblad, Professor Serge Gauthier, Professor Jean-Marie Maloteaux
Published by Birkhäuser Basel
ISBN: 978-3-0348-9591-0
DOI: 10.1007/978-3-0348-7842-5
Table of Contents:
Introduction -- Part I: Biological correlates of Alzheimer disease: Chapter 1: Alzheimer disease. Chapter 2: Neurological dysfunctions in Alzheimer disease. Chapter 3: Pharmacology of Alzheimer disease. Chapter 4: Molecular genetics of Alzheimer disease. Chapter 5: Promises of animal models of Alzheimer disease -- Part II: Neuropsychology of Alzheimer disease: Chapter 6: What is memory? Chapter 7: Mild Cognitive Impairment. Chapter 8: Cognitive impairment in Alzheimer disease. Chapter 9: Behavioral and psychological impairments. Chapter 10: Assessment of memory. Chapter 11: Functional abilities and behavioral symptom assessments -- Part III: Treatment of Alzheimer disease: Chapter 12: Pharmacological treatments of cognitive deficits. Chapter 13: Pharmacological treatment of neuropsychiatric symptoms. Chapter 14: Psychological support and cognitive rehabilitation. Chapter 15: Discussion and conclusion
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology
Includes bibliographical references and index
Author: Dr. Gérard Emilien, Dr. Cécile Durlach, Dr. Kenneth Lloyd Minaker, Professor Bengt Winblad, Professor Serge Gauthier, Professor Jean-Marie Maloteaux
Published by Birkhäuser Basel
ISBN: 978-3-0348-9591-0
DOI: 10.1007/978-3-0348-7842-5
Table of Contents:
- Alzheimer disease
- Neurological dysfunctions in Alzheimer disease
- Pharmacology of Alzheimer disease
- Molecular genetics of Alzheimer disease
- Promises of animal models of Alzheimer disease
- What is memory?
- Mild cognitive impairment
- Cognitive impairment in Alzheimer disease
- Behavioral and psychological impairments
- Assessment of memory
- Functional abilities and behavioral symptom assessments
- Pharmacological treatment of cognitive deficits
- Pharmacological treatment of neuropsychiatric symptoms
- Psychological support and cognitive rehabilitation
- Discussion and conclusion
Introduction -- Part I: Biological correlates of Alzheimer disease: Chapter 1: Alzheimer disease. Chapter 2: Neurological dysfunctions in Alzheimer disease. Chapter 3: Pharmacology of Alzheimer disease. Chapter 4: Molecular genetics of Alzheimer disease. Chapter 5: Promises of animal models of Alzheimer disease -- Part II: Neuropsychology of Alzheimer disease: Chapter 6: What is memory? Chapter 7: Mild Cognitive Impairment. Chapter 8: Cognitive impairment in Alzheimer disease. Chapter 9: Behavioral and psychological impairments. Chapter 10: Assessment of memory. Chapter 11: Functional abilities and behavioral symptom assessments -- Part III: Treatment of Alzheimer disease: Chapter 12: Pharmacological treatments of cognitive deficits. Chapter 13: Pharmacological treatment of neuropsychiatric symptoms. Chapter 14: Psychological support and cognitive rehabilitation. Chapter 15: Discussion and conclusion
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology
Includes bibliographical references and index
